Omari Tablet 25 mg contains Omarigliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. This medication helps control blood glucose levels in adults when diet and exercise alone are insufficient. Omarigliptin works by enhancing the body’s natural incretin system, which increases insulin secretion in response to meals and reduces glucagon release, improving overall glucose regulation.

A key advantage of Omari Tablet 25 mg is its once-weekly dosing regimen, offering convenience and improving patient adherence. The long-acting DPP-4 inhibitor helps reduce fasting and postprandial blood sugar levels, while minimizing the risk of hypoglycemia when used appropriately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Maintains glycemic control in type 2 diabetes mellitus

• Reduces fasting and postprandial blood glucose levels

• Enhances meal-dependent insulin secretion

• Suppresses excessive glucagon release to stabilize blood sugar

• Weight-neutral effect with minimal risk of hypoglycemia

• Convenient once-weekly dosing improves adherence

Mechanism of Action

Omarigliptin exerts its therapeutic effect as a DPP-4 enzyme inhibitor:

1. DPP-4 Inhibition: Blocks the breakdown of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).

2. Enhanced Insulin Release: Incretins stimulate insulin secretion in response to elevated blood glucose after meals.

3. Reduced Glucagon Secretion: Prevents excessive glucose release from the liver during fasting.

4. Improved Glycemic Control: Balances insulin and glucagon levels to maintain stable blood glucose throughout the day.

This dual action helps patients achieve effective glycemic control with a convenient weekly dose.

Indications

Omari Tablet 25 mg is indicated for:

• Adults with type 2 diabetes mellitus to improve glycemic control

• Patients inadequately controlled by diet and exercise alone

• Adjunct therapy with other oral antidiabetic medications or insulin when necessary

• Adults seeking a once-weekly antidiabetic regimen for convenience and adherence

Dosage and Administration

• Recommended dose: 25 mg orally, once weekly, or as directed by a healthcare professional.

• Can be taken with or without food, preferably at the same time each week.

• Maintain diet and exercise programs to optimize blood glucose control.

• Regular monitoring of blood glucose levels is advised to assess efficacy and adjust therapy if necessary.

Precautions and Warnings

• Not suitable for type 1 diabetes mellitus or for treating diabetic ketoacidosis.

• Use caution in patients with renal impairment; dose adjustments may be needed.

• Inform your physician of all medications to avoid drug interactions.

• Discontinue and seek medical attention if severe allergic reactions occur.

Possible Side Effects

Omari Tablet 25 mg is generally well-tolerated. Common side effects include:

• Nasopharyngitis (common cold)

• Headache

• Mild gastrointestinal discomfort such as nausea

Hypoglycemia is rare when used alone but may occur when combined with sulfonylureas or insulin. Rare cases of allergic reactions may also occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store below 30°C in a dry, cool place, protected from light and moisture. Keep out of reach of children.

Omari Tablet 25 mg provides effective once-weekly glycemic control for type 2 diabetes, enhancing insulin secretion, reducing glucagon levels, and helping patients maintain stable blood glucose while improving adherence through a convenient dosing schedule.